WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2009

Feb 26, 2009

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2009-02-24

Reporting Person: MOREL DONALD E JR (Chair of the Board & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2009-02-24	Common Stock	A	17282	$32.09	Acquired	240560.6644	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2009-02-24	Stock Option (Right to Buy)	$32.09	A	100000	Acquired	2019-02-24	Common Stock (100000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1109.2237	Indirect
Common Stock	27740.9192	Indirect

Footnotes

F1: Shares represent the portion of the Performance Vesting Restricted Share Awards granted in 2006 that have vested for performance period V.

F2: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.